Crewe Advisors LLC Bio N Tech Se Transaction History
Crewe Advisors LLC
- $856 Million
- Q1 2024
A detailed history of Crewe Advisors LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Crewe Advisors LLC holds 809 shares of BNTX stock, worth $65,116. This represents 0.01% of its overall portfolio holdings.
Number of Shares
809Holding current value
$65,116% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
327Shares Held
40.4MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.36MShares$673 Million0.61% of portfolio
-
Primecap Management CO Pasadena, CA4.81MShares$387 Million0.34% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$307 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$279 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$276 Million1.76% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $19.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...